Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (29862)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 15, 2020 (publication date) through Jun 12, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dominari A, Hathaway III D, Pandav K, Matos W, Biswas S, Reddy G, Thevuthasan S, Khan MA, Mathew A, Makkar SS, Zaidi M, Maher M, Beas R, Castaneda V, Paul T, Halpern J, Baralt D. Thymosin alpha 1: A comprehensive review of the literature. World J Virol 2020; 9(5): 67-78 [PMID: 33362999 DOI: 10.5501/wjv.v9.i5.67] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v9/i5/67.htm |
| Number | Citing Articles |
| 1 |
Anastasios I. Birmpilis, Panagiotis Vitsos, Ioannis V. Kostopoulos, Lillian Williams, Kyriaki Ioannou, Pinelopi Samara, Chrysoula-Evangelia Karachaliou, Ioannis F. Voutsas, Elena Alyfanti, Nikolaos Angelis, Nikolaos G. Gavalas, Themis Gkraikou, Niki Kappa, Eleftheria Klagkou, Persefoni Klimentzou, Spiridoula Nikou, Nikos E. Papaioannou, Margarita Skopeliti, David Toukli, Meletios-Athanasios Dimopoulos, Aristotelis Bamias, Evangelia Livaniou, Hubert Kalbacher, Ourania E. Tsitsilonis, Wolfgang Voelter. Prothymosin α and its C-Terminal Immunoreactive Decapeptide
Show No Evidence of Acute Toxicity: A Preliminary In Silico, In Vitro
and In Vivo Investigation. Current Medicinal Chemistry 2022; 29(42): 6463 doi: 10.2174/0929867328666211117093401
|
| 2 |
Fadi Shehadeh, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, Matthew Kaczynski, Eleftherios Mylonakis. A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection. The Journal of Infectious Diseases 2023; 227(2): 226 doi: 10.1093/infdis/jiac362
|
| 3 |
Michael Quagliata, Anna Maria Papini, Paolo Rovero. Therapeutic applications of thymosin peptides: a patent landscape 2018-present. Expert Opinion on Therapeutic Patents 2023; 33(12): 865 doi: 10.1080/13543776.2023.2298833
|
| 4 |
Association between pretreatment lymphocyte count and efficacy of immune-enhancing therapy in acute necrotising pancreatitis: a post-hoc analysis of the multicentre, randomised, placebo-controlled TRACE trial. eClinicalMedicine 2023; 58: 101915 doi: 10.1016/j.eclinm.2023.101915
|
| 5 |
Yatin Mehta, Subhal B Dixit, Kapil Zirpe, Randhir Sud, Palepu B Gopal, Parvaiz A Koul, Vijay K Mishra, Abdul S Ansari, Vijay S Chamle. Therapeutic Approaches in Modulating the Inflammatory and Immunological Response in Patients With Sepsis, Acute Respiratory Distress Syndrome, and Pancreatitis: An Expert Opinion Review. Cureus 2021; doi: 10.7759/cureus.18393
|
| 6 |
Adriana Marques, Carla Torre, Rui Pinto, Bruno Sepodes, João Rocha. Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms. Journal of Clinical Medicine 2023; 12(8): 2892 doi: 10.3390/jcm12082892
|
| 7 |
Christian Bode, Sebastian Weis, Andrea Sauer, Pedro Wendel-Garcia, Sascha David. Targeting the host response in sepsis: current approaches and future evidence. Critical Care 2023; 27(1) doi: 10.1186/s13054-023-04762-6
|
| 8 |
Wilson Savino, Ailin Lepletier. Thymus-derived hormonal and cellular control of cancer. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1168186
|
| 9 |
Viktor Wixler, Rafael Leite Dantas, Georg Varga, Yvonne Boergeling, Stephan Ludwig. Small Spleen Peptides (SSPs) Shape Dendritic Cell Differentiation through Modulation of Extracellular ATP Synthesis Profile. Biomolecules 2024; 14(4): 469 doi: 10.3390/biom14040469
|
| 10 |
Daniela Ricci, Marilena Paola Etna, Martina Severa, Stefano Fiore, Fabiana Rizzo, Marco Iannetta, Massimo Andreoni, Stefano Balducci, Paola Stefanelli, Anna Teresa Palamara, Eliana Marina Coccia. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model. International Immunopharmacology 2023; 117: 109996 doi: 10.1016/j.intimp.2023.109996
|
| 11 |
Valéria Bumiller-Bini Hoch, Ana Flávia Kohler, Danillo G. Augusto, Sara Cristina Lobo-Alves, Danielle Malheiros, Gabriel Adelman Cipolla, Angelica Beate Winter Boldt, Karin Braun-Prado, Michael Wittig, Andre Franke, Claudia Pföhler, Margitta Worm, Nina van Beek, Matthias Goebeler, Miklós Sárdy, Saleh Ibrahim, Hauke Busch, Enno Schmidt, Jennifer Elisabeth Hundt, Patrícia Savio de Araujo-Souza, Maria Luiza Petzl-Erler. Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus. Viruses 2022; 14(5): 879 doi: 10.3390/v14050879
|
| 12 |
María del Mar Pozo-Balado, Ángel Bulnes-Ramos, Israel Olivas-Martínez, Vanesa Garrido-Rodríguez, Carmen Lozano, Ana I. Álvarez-Ríos, Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara, Juan Antonio Santamaría, Rafael Bernal, María Francisca González-Escribano, Manuel Leal, Yolanda M. Pacheco. Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home. Immunity & Ageing 2023; 20(1) doi: 10.1186/s12979-023-00334-y
|
| 13 |
ChenLu Huang, Ling Fei, Wei Xu, WeiXia Li, XuDong Xie, Qiang Li, Liang Chen. Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.664776
|
| 14 |
Yafeng Liu, Jibin Lu. Mechanism and clinical application of thymosin in the treatment of lung cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1237978
|
| 15 |
Muhammad Shahbaz Aslam, Syed Zohaib Javaid Zaidi, Rabail Hassan Toor, Iram Gull, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed, Muhammad Amin Athar, Christian Harito, Sammer-ul Hassan. Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect. Materials 2021; 14(12): 3318 doi: 10.3390/ma14123318
|
| 16 |
Andrea Öhlander, Carsten Lüdtke, Artur Sahakjan, Richard E. Johnsson. N‐Butylpyrrolidinone is an equally good solvent as N,N‐dimethylformamide for microwave assisted solid phase peptide synthesis. Journal of Peptide Science 2024; doi: 10.1002/psc.3612
|
| 17 |
Shuai Wang, Wei Wei, Hui Yong, Zhao Zhang, Xiping Zhang, Xuejun Zhang, Shue Wang. Synergistic anti-cancer and attenuation effects of thymosin on chemotherapeutic drug vinorelbine in tumor-bearing zebrafish. Biomedicine & Pharmacotherapy 2023; 162: 114633 doi: 10.1016/j.biopha.2023.114633
|
| 18 |
Arto Yuwono Soeroto, Hendarsyah Suryadinata, Theo Audi Yanto, Timotius Ivan Hariyanto. The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression. Inflammopharmacology 2023; 31(6): 3317 doi: 10.1007/s10787-023-01354-2
|
| 19 |
念 刘. Current Status of Prognostic Evaluation Model and Treatment of Acute-on-Chronic Liver Failure. Advances in Clinical Medicine 2024; 14(04): 2500 doi: 10.12677/acm.2024.1441320
|
| 20 |
Yan Wu, Lingling He, Yongping Guo, Niansong Wang. Risk Factors and Drug Efficacy for Severe Illness in Hemodialysis Patients Infected with the Omicron Variant of COVID-19. Kidney and Blood Pressure Research 2023; 48(1): 642 doi: 10.1159/000534192
|
| 21 |
Zirui Wang, Cong Wang, Xiaohua Fei, Haixing Wu, Peiqin Niu, Changxing Shen. Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms. Pneumonia 2023; 15(1) doi: 10.1186/s41479-023-00116-6
|
| 22 |
Tao Liu, Shengdong Liu, Tao Li, Jingjing Zhang. Thymosin a1 use is not associated with reduced COVID-19 mortality. The American Journal of Emergency Medicine 2022; 53: 252 doi: 10.1016/j.ajem.2021.04.043
|
| 23 |
Ángel Bulnes-Ramos, María Mar Pozo-Balado, Israel Olivas-Martínez, Vanesa Garrido-Rodríguez, Gabriel Bernal-Blanco, Alejandro Suárez-Benjumea, Ana Isabel Álvarez-Ríos, Carmen Lozano, Carmen González-Corvillo, Marta Suñer-Poblet, Francisco Manuel González-Roncero, Berta Sánchez, Isabel Maldonado-Calzado, José Manuel Lara-Ruiz, María Francisca Gonzalez-Escribano, Yolanda María Pacheco. Factors associated with the humoral response after three doses of COVID-19 vaccination in kidney transplant recipients. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1099079
|
| 24 |
Lisa K. Torres, Peter Pickkers, Tom van der Poll. Sepsis-Induced Immunosuppression. Annual Review of Physiology 2022; 84(1): 157 doi: 10.1146/annurev-physiol-061121-040214
|
| 25 |
Enrico Garaci, Maurizio Paci, Claudia Matteucci, Claudio Costantini, Paolo Puccetti, Luigina Romani. Phenotypic drug discovery: a case for thymosin alpha-1. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1388959
|
| 26 |
Cesidio Giuliani, Sara Verrocchio, Fabio Verginelli, Ines Bucci, Antonino Grassadonia, Giorgio Napolitano. Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter “Tissue-Specific” Region. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.749609
|